Table 3. Resolved fevers treated with antimalarials (AM) within 48hrs by source and type.

	Aug-06	Jan-07	Apr-07	Jun-07
Resolved fevers	118	90	85	89
Total AM treatment for resolved fevers in formal health sector within 48hrs	12	13	16	15
AL	1 (0.8%)	4 (4.4%)	7 (8.2%)	10 (11.2%)
ARM/DHA/ATS	0	0	0	0
QN	0	1 (1.1%)	0	1 (1.1%)
AQ	4 (3.4%)	4 (4.4%)	9 (10.6%)	3 (3.4%)
Monotherapy combinations (AQ and QN)	0	2 (2.2%)	0	0
SP	7 (5.9%)	2 (2.2%)	0	1 (1.1%)
CQ	0	0	0	0
Total AM treatment for resolved fevers in retail sector within 48hrs	7	8	3	7
AL	0	1 (1.1%)	0	0
ARM/DHA/ATS	0	1 (1.1%)	0	1 (1.1%)
QN	0	0	0	0
AQ	3 (2.5%)	4 (4.4%)	2 (2.4%)	2 (2.2%)
Monotherapy combinations (SP and CQ)	0	0	0	0
SP	3 (2.5%)	2 (2.2%)	0	4 (4.5%)
CQ	1 (0.8%)	0	1 (1.2%)	0
Total AM treatment for resolved fevers through self medication and community pharmacist within 48 hours	0	3	3	3
AL	0	0	1 (1.2%)	0
ARM/DHA/ATS	0	1 (1.1%)	0	0
QN	0	0	0	1 (1.1%)
AQ	0	2 (2.2%)	2 (2.4%)	0
Monotherapy combinations	0	0	0	0
SP	0	0	0	2 (2.2%)
CQ	0	0	0	0

AL: Artemether Lumefantrine; ARM: Artemether; DHA: Dihydroartemisinin; ATS: Artesunate; QN: Quinine; SP: Sulphadoxine pyrimethamine; CQ: Chloroquine; AQ: Amodiaquine